29/04/2026
✨ A proud moment for Indian dermatology 🇮🇳
With Sun Pharmaceutical Industries bringing Ilumya (Tildrakizumab) to India, we now have access to an advanced global therapy for psoriasis.
For those struggling with:
🔸 Stubborn plaques
🔸 Recurrent flares
🔸 Impact on confidence & quality of life
This marks another step forward in long-term disease control and convenience of treatment.
Not just about a drug—
It’s about hope, accessibility, and progress in psoriasis care in India ❤️